$Quantum-Si (QSI.US)$$Avantor (AVTR.US)$ Avantor to Distribute Quantum-Si’s Next-Generation Protein Sequencing™ Technology Quantum-Si (Nasdaq: QSI) has entered into a distribution agreement with Avantor (NYSE: AVTR) for its Next-Generation Protein Sequencing (NGPS) technology portfolio in the U.S. and Canadian markets. The collaboration will enable broader access to QSI's proteomics solutions across various laboratory settings. The platform utilizes single-molecule sequencing technology...
"Paper trading with a $200K balance in the Positive Earnings Challenge. Managing 17 positions and holding strong at rank 1,523. Focused on refining my strategies and steadily building gains for long-term growth."
A low ROE and high debt usage is unattractive. High quality businesses can achieve high ROE without debt. If two companies have equal ROE, the less indebted one is preferred.
Avantor's high P/E is buoyed by investor expectations of robust future growth and an outstanding earnings outlook, supported by mid-term rates of earnings growth. As long as conditions hold, these factors will sustain the stock’s price.
Avantor remains good investment as it is undervalued offering future growth prospects. Despite market risks and volatility, investors are urged to consider other factors like company's balance sheet strength before deciding.